• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Subclinical Hypothyroidism Is a Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.亚临床甲状腺功能减退是2型糖尿病患者发生糖尿病视网膜病变的危险因素。
Med J Islam Repub Iran. 2021 Dec 30;35:186. doi: 10.47176/mjiri.35.186. eCollection 2021.
2
Subclinical Hypothyroidism in Patients with Diabetic Retinopathy: Role of Vascular Endothelial Growth Factor.糖尿病视网膜病变患者亚临床甲状腺功能减退症:血管内皮生长因子的作用。
Endocr Metab Immune Disord Drug Targets. 2022;22(5):502-509. doi: 10.2174/1871530321666210809151258.
3
Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes.亚临床甲状腺功能减退与韩国 2 型糖尿病患者严重糖尿病视网膜病变的关系。
Endocr J. 2011;58(12):1065-70. doi: 10.1507/endocrj.ej11-0199. Epub 2011 Sep 17.
4
An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients.亚临床甲状腺功能减退症与 2 型糖尿病患者视力威胁性糖尿病视网膜病变之间的关联。
Diabetes Care. 2010 May;33(5):1018-20. doi: 10.2337/dc09-1784. Epub 2010 Feb 11.
5
Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.2型糖尿病患者亚临床甲状腺功能减退与非酒精性脂肪性肝病的关联:一项横断面研究
Adv Biomed Res. 2022 Dec 26;11:124. doi: 10.4103/abr.abr_15_21. eCollection 2022.
6
Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis.亚临床甲状腺功能减退与2型糖尿病:一项系统评价与荟萃分析
PLoS One. 2015 Aug 13;10(8):e0135233. doi: 10.1371/journal.pone.0135233. eCollection 2015.
7
Subclinical hypothyroidism contributes to poor glycemic control in patients with type 2 diabetes mellitus, and ellagic acid attenuates methimazole-induced abnormal glucose metabolism in mice model.亚临床甲状腺功能减退症导致 2 型糖尿病患者血糖控制不佳,鞣花酸可减轻甲巯咪唑诱导的小鼠模型异常葡萄糖代谢。
J Food Biochem. 2021 Jun;45(6):e13753. doi: 10.1111/jfbc.13753. Epub 2021 May 5.
8
Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study.亚临床甲状腺功能减退症与 2 型糖尿病患者增生性糖尿病视网膜病变的关系:一项病例对照研究。
Tohoku J Exp Med. 2010 Dec;222(4):303-10. doi: 10.1620/tjem.222.303.
9
Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.韩国2型糖尿病患者糖尿病视网膜病变的临床病程及危险因素
Diabetes Metab J. 2016 Dec;40(6):482-493. doi: 10.4093/dmj.2016.40.6.482. Epub 2016 Oct 5.
10
Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus.2型糖尿病患者亚临床甲状腺功能减退与糖尿病肾病之间的关联。
Endocr J. 2014;61(10):1011-8. doi: 10.1507/endocrj.ej14-0206. Epub 2014 Aug 7.

引用本文的文献

1
Prognostic Role of TSH Within Euthyroid T2DM Patients with Retinopathy: A 3-Year Cohort Study.促甲状腺激素在伴有视网膜病变的甲状腺功能正常的2型糖尿病患者中的预后作用:一项为期3年的队列研究。
Diseases. 2025 Jul 12;13(7):217. doi: 10.3390/diseases13070217.
2
Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study.甲状腺功能正常的2型糖尿病患者甲状腺相关激素与糖尿病视网膜病变的相关性:一项回顾性研究
Diabetes Metab Syndr Obes. 2024 Mar 26;17:1481-1490. doi: 10.2147/DMSO.S455428. eCollection 2024.
3
Identification of biomarkers associated with immune scores in diabetic retinopathy.鉴定与糖尿病视网膜病变免疫评分相关的生物标志物。
Front Endocrinol (Lausanne). 2023 Oct 5;14:1228843. doi: 10.3389/fendo.2023.1228843. eCollection 2023.
4
Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European population.评估调节甲状腺功能的遗传因素与糖尿病微血管并发症之间的关联:欧洲人群的两样本孟德尔随机研究。
Front Endocrinol (Lausanne). 2023 Feb 28;14:1126339. doi: 10.3389/fendo.2023.1126339. eCollection 2023.
5
Association Between Sensitivity to Thyroid Hormone Indices and Diabetic Retinopathy in Euthyroid Patients with Type 2 Diabetes Mellitus.甲状腺功能正常的2型糖尿病患者甲状腺激素指标敏感性与糖尿病视网膜病变之间的关联
Diabetes Metab Syndr Obes. 2023 Feb 27;16:535-545. doi: 10.2147/DMSO.S399910. eCollection 2023.

本文引用的文献

1
Association Between Plasma Homocysteine Levels and Subclinical Hypothyroidism in Adult Subjects: A Meta-Analysis.血浆同型半胱氨酸水平与成年亚临床甲状腺功能减退症的关系:荟萃分析。
Horm Metab Res. 2020 Sep;52(9):625-638. doi: 10.1055/a-1199-2633. Epub 2020 Jul 6.
2
gp91, a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism.gp91是一种评估氧化应激的新型生物标志物,在亚临床甲状腺功能减退症中升高。
Int J Endocrinol. 2020 May 6;2020:3161730. doi: 10.1155/2020/3161730. eCollection 2020.
3
Endothelial Function in Patients with Subclinical Hypothyroidism: A Meta-Analysis.亚临床甲状腺功能减退症患者的血管内皮功能:一项荟萃分析。
Horm Metab Res. 2019 Nov;51(11):691-702. doi: 10.1055/a-1018-9564. Epub 2019 Nov 4.
4
Association of Retinopathy and Insulin Resistance: NHANES 2005-2008.糖尿病视网膜病变与胰岛素抵抗的相关性:NHANES 2005-2008。
Curr Eye Res. 2020 Feb;45(2):173-176. doi: 10.1080/02713683.2019.1659977. Epub 2019 Aug 28.
5
Subclinical Hypothyroidism: A Review.亚临床甲状腺功能减退症:综述。
JAMA. 2019 Jul 9;322(2):153-160. doi: 10.1001/jama.2019.9052.
6
Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.血脂异常与糖尿病视网膜病变之间的关系:一项系统评价与荟萃分析。
Medicine (Baltimore). 2018 Sep;97(36):e12283. doi: 10.1097/MD.0000000000012283.
7
Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies.亚临床甲状腺功能减退症与心血管疾病和全因死亡率的风险:前瞻性队列研究的荟萃分析。
Thyroid. 2018 Sep;28(9):1101-1110. doi: 10.1089/thy.2017.0414. Epub 2018 Aug 17.
8
Triiodothyronine Potentiates Vasorelaxation via PKG/VASP Signaling in Vascular Smooth Muscle Cells.三碘甲状腺原氨酸通过蛋白激酶G/血管舒张刺激磷蛋白信号通路增强血管平滑肌细胞的血管舒张作用。
Cell Physiol Biochem. 2017;41(5):1894-1904. doi: 10.1159/000471938. Epub 2017 Apr 4.
9
Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes.伊朗2型糖尿病患者的亚临床甲状腺功能减退与糖尿病肾病
J Endocrinol Invest. 2017 Mar;40(3):289-295. doi: 10.1007/s40618-016-0560-3. Epub 2016 Oct 13.
10
Relationship between Diabetic Retinopathy and Subclinical Hypothyroidism: a meta-analysis.糖尿病视网膜病变与亚临床甲状腺功能减退症之间的关系:一项荟萃分析。
Sci Rep. 2015 Jul 20;5:12212. doi: 10.1038/srep12212.

亚临床甲状腺功能减退是2型糖尿病患者发生糖尿病视网膜病变的危险因素。

Subclinical Hypothyroidism Is a Risk Factor for Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.

作者信息

Heidari Zahra, Asadzadeh Reza

机构信息

Department of Endocrinology and Metabolism, Zahedan University of Medical Sciences, Zahedan, Iran.

School of Biology, Damghan University, Damghan, Iran.

出版信息

Med J Islam Repub Iran. 2021 Dec 30;35:186. doi: 10.47176/mjiri.35.186. eCollection 2021.

DOI:10.47176/mjiri.35.186
PMID:36042831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9391758/
Abstract

Diabetic retinopathy (DR) is one of the most common complications of diabetes. The known risk factors for microvascular complications are uncontrolled diabetes, duration of diabetes, dyslipidemia, and hypertension. In addition to these conventional risk factors, other risk factors, such as hypothyroidism have recently been suggested. Adult patients with type 2 diabetes mellitus (T2DM) were recruited. All patients were evaluated for retinopathy. Various clinical and biochemical parameters, including thyroid function tests, were assessed and compared between groups. In this study, 928 patients with (T2DM) were included. Of all patients, 376 (40.52%) had DR. In patients with retinopathy, 115 (30.58%) had proliferative and 261 (69.42%) had nonproliferative retinopathy. In patients with nonproliferative DR, 34.48%, 32.95%, and 32.57% had mild, moderate, and severe nonproliferative DR, respectively. Of all patients, 91 (9.8%) had subclinical hypothyroidism. There was a significant relationship between subclinical hypothyroidism (SCH) and DR in these patients. In patients with retinopathy, 14.4% and in patients without retinopathy, 6.7% had SCH (p<0.001). In univariate logistic regression analysis, the chance of developing DR in patients with SCH was 2.33 times higher than patients without subclinical hypothyroidism, each unit increase in the thyroid-stimulating hormone significantly increases the chance of developing DR by 13%. The present study showed that in the population of patients with (T2DM), SCH is associated with DR, regardless of the conventional risk factors.

摘要

糖尿病视网膜病变(DR)是糖尿病最常见的并发症之一。已知微血管并发症的危险因素包括糖尿病控制不佳、糖尿病病程、血脂异常和高血压。除了这些传统危险因素外,最近还提出了其他危险因素,如甲状腺功能减退。招募了成年2型糖尿病(T2DM)患者。所有患者均接受视网膜病变评估。评估并比较了各组的各种临床和生化参数,包括甲状腺功能测试。本研究纳入了928例T2DM患者。在所有患者中,376例(40.52%)患有DR。在患有视网膜病变的患者中,115例(30.58%)患有增殖性视网膜病变,261例(69.42%)患有非增殖性视网膜病变。在患有非增殖性DR的患者中,分别有34.48%、32.95%和32.57%患有轻度、中度和重度非增殖性DR。在所有患者中,91例(9.8%)患有亚临床甲状腺功能减退。这些患者中亚临床甲状腺功能减退(SCH)与DR之间存在显著关系。在患有视网膜病变的患者中,14.4%患有SCH,在没有视网膜病变的患者中,6.7%患有SCH(p<0.001)。在单因素逻辑回归分析中,SCH患者发生DR的几率比没有亚临床甲状腺功能减退的患者高2.33倍,促甲状腺激素每增加一个单位,发生DR的几率显著增加13%。本研究表明,在T2DM患者群体中,无论传统危险因素如何,SCH都与DR相关。